Cargando…
A New Tool for CRISPR-Cas13a-BasedCancer Gene Therapy
Autores principales: | Gao, Jinliang, Luo, Tao, Lin, Na, Zhang, Shuyan, Wang, Jinke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591403/ https://www.ncbi.nlm.nih.gov/pubmed/34820506 http://dx.doi.org/10.1016/j.omto.2021.10.007 |
Ejemplares similares
-
A New Tool for CRISPR-Cas13a-Based Cancer Gene Therapy
por: Gao, Jinliang, et al.
Publicado: (2020) -
Correction to: CRISPR/Cas: a potential gene-editing tool in the nervous system
por: Gao, Yanxia, et al.
Publicado: (2021) -
Gene interfered-ferroptosis therapy for cancers
por: Gao, Jinliang, et al.
Publicado: (2021) -
Correction: CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool
por: Stemmer, Manuel, et al.
Publicado: (2017) -
CRISPR-Cas: ‘The Multipurpose Molecular Tool’ for Gene Therapy and Diagnosis
por: Sauvagère, Stéphane, et al.
Publicado: (2023)